If the financing is to be fairly vanilla as BobW depicts, then I have to agree that there's a real good chance that part of the deal will involve Al getting some more shares in return for canelation of some or all of the debt MNKD owes to Al.

Hoping for some foreign entity to ride to the rescue, even if it will upset the FDA some. Raising all the money needed just by offering new shares is pretty rough on existing shareholders, although we theoretically can take advantage of any dip in price as the result of the dilution.